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Improving the enrichment procedure for Enterobacteriaceae
detection
Abstract
The current ISO standard method for detection of Enterobacteriaceae (21528-1:2004) includes
enrichment in EE broth, which has been shown to be inhibitory to some members of this family, notably
Cronobacter spp. A shortened procedure omitting the EE broth has been proposed, however competition
from Gram-positive flora may be detrimental to the effective recovery of low levels of target organisms
in some sample matrices. In this study we investigated novel cost effective modifications, designed to
improve ISO 21528-1:2004 for the detection of Enterobacteriaceae. Initial experiments used a
worse-case scenario involving stressed Enterobacteriaceae strains known to grow poorly in laboratory
media as well as representative background competitors from powdered milk. The interaction between
the Enterobacteriaceae and their competitors was characterised and additives to enhance the growth of
target strains over non-target strains were investigated.  Supplementation of BPW with 40 µM 8
hydroxyquinoline, 0.5g L-1 ammonium iron(III) citrate, 0.1 g  L-1 sodium deoxycholate and 0.1g L-1
sodium pyruvate (BPW-S) improved the recovery of Enterobacteriaceae  from artificially and naturally
contaminated samples. This improvement of the pre-enrichment broth may also be of interest for
methods designed to detect specific foodborne pathogens belonging to the Enterobacteriaceae (e.g.
Salmonella spp., Cronobacter spp.) that require a pre-enrichment step in BPW.  
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Abstract 17 
The current ISO standard method for detection of Enterobacteriaceae (21528-1:2004) includes 18 
enrichment in EE broth which has been shown to be inhibitory to some members of this family, notably 19 
Cronobacter spp. A shortened procedure omitting the EE broth has been proposed, however competition from 20 
Gram-positive flora may be detrimental to the effective recovery of low levels of target organisms in some 21 
sample matrices. In this study we investigated novel cost effective modifications, designed to improve ISO 22 
21528-1:2004 for the detection of Enterobacteriaceae. Initial experiments used a worse-case scenario involving 23 
stressed Enterobacteriaceae strains known to grow poorly in laboratory media as well as representative 24 
background competitors from powdered milk. The interaction between the Enterobacteriaceae and their 25 
competitors was characterised and additives to enhance the growth of target strains over non-target strains were 26 
investigated. 27 
 Supplementation of BPW with 40 µM 8-hydroxyquinoline, 0.5g L-1 ammonium iron(III) citrate, 0.1 g 28 
L-1 sodium deoxycholate and 0.1g L-1 sodium pyruvate (BPW-S) improved the recovery of Enterobacteriaceae 29 
from artificially and naturally contaminated samples. This improvement of the pre-enrichment broth may also be 30 
of interest for methods designed to detect specific foodborne pathogens belonging to the Enterobacteriaceae 31 
(e.g. Salmonella spp., Cronobacter spp.)  that require a pre-enrichment step in BPW. 32 
 33 
34 
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 34 
1. Introduction 35 
 36 
The family Enterobacteriaceae are useful indicators for verification of hygiene processes in food 37 
production facilities (Anonymous, 2005). The current ISO standard method 21528-1:2004 (Anonymous, 2004) 38 
comprises pre-enrichment in buffered peptone water (BPW), followed by enrichment in Enterobacteriaceae 39 
enrichment (EE) broth, which is then streaked on violet red bile glucose (VRBG) agar. Typical colonies on 40 
VRBG are confirmed as Enterobacteriaceae based on negative oxidase activity and positive glucose 41 
fermentation. 42 
It has been reported that some potentially pathogenic strains of Enterobacteriaceae do not grow well in 43 
EE broth (Gurtler and Beuchat, 2005; Iversen and Forsythe, 2007; Joosten et al., 2008).  This challenges the 44 
reliability of the results obtained with the current ISO standard as an indicator of poor hygiene, inadequate 45 
processing or post-process contamination of foods.  46 
A revision to the ISO standard method (21528-1:2004) has been proposed in which the selective 47 
enrichment in EE broth is omitted and samples pre-enriched in BPW are directly plated on VRBG agar (Joosten 48 
et al., 2008). This method has been shown to give comparable results to ISO 21528-1:2004 and also reduces the 49 
test time facilitating quicker release of product.  Removal of the selective enrichment in EE broth means that 50 
any non-Enterobacteriaceae present in the sample that are able to grow in BPW during pre-enrichment may 51 
compete with the Enterobacteriaceae reducing the numbers of target colonies that are transferred onto the 52 
VRBG agar. This may be a consideration for matrices that are likely to contain low numbers of stressed 53 
Enterobacteriaceae and relatively high numbers of thermoduric spores, such as powdered milk and infant 54 
formulae (Murphy et al., 1999).   55 
Bacillus spp. are a genera of Gram-positive rods that produce endospores as a dormant state allowing 56 
them to deal with extreme conditions such as high temperatures and desiccation (Nicholson et al., 2000; Huck et 57 
al., 2008). The ability to survive these conditions means that Bacillus spp. are frequently found as members of 58 
the microflora of powders (Gabis et al., 1970; Anderton, 1986; Antai, 1988; Crielly et al., 1994; Kunene et al., 59 
1999; Rueckert et al., 2005; Ronimus et al., 2006; Reyes et al., 2007). Additionally, some Bacillus spp. produce 60 
antimicrobial molecules that are active against Gram-negative organisms such as polymyxin and colistin (Katz 61 
and Demain, 1977; He et al., 2007). It has been shown that for some samples, such as powdered infant formula, 62 
addition of vancomycin to inhibit Gram-positive microflora during the pre-enrichment resulted in a trend for 63 
4 
 
increased recovery of Enterobacteriaceae (Joosten et al., 2007).  Vancomycin is heat labile and is an expensive 64 
additive given the volumes of pre-enrichment media used.  Also concern has been expressed in relation to the 65 
possible spread of vancomycin resistance genes (Willems et al., 2005).  The compounds 8-hydroxyquinoline and 66 
sodium deoxycholate are heat stable and economically viable as possible alternatives to vancomycin. Sodium 67 
deoxycholate is a water soluble anionic detergent that is found in the intestine of higher animals (Haselwood, 68 
1967). It is the selective agent in bile salts (Stacey and Webb, 1947; D'Mello et al., 1987) and has been used as 69 
an antimicrobial agent in culture media for more than 100 years (MacConkey, 1905).  The monoprotic bidentate 70 
chelating agent 8-hydroxyquinoline has been used in topical ointments (Tanzer et al., 1978) and as a potential 71 
anti-plaque agent in dental washes (Depalma et al. 1975; Tanzer et al. 1978). The activity of 8-hydroxyquinoline 72 
against Gram-positive organisms has been reported to be 10-100 fold higher than against Gram-negative 73 
organisms (Albert et al., 1947).  74 
This study investigates novel cost effective modifications, designed to improve ISO 21528-1:2004 for 75 
the detection of Enterobacteriaceae. Initial experiments used a worse-case scenario involving stressed 76 
Enterobacteriaceae strains known to grow poorly in laboratory media and representative Bacillus spp. from 77 
powdered milk. The interaction between the Enterobacteriaceae and their competitors was characterised and 78 
additives to enhance the growth of target strains over non-target strains were investigated. 79 
 80 
 81 
2. Methods 82 
 83 
2.1. Bacterial isolates used in this study. 84 
 85 
The strains used in this study were obtained from the culture collections at Nestlé Research Centre, 86 
Lausanne, Switzerland; the Institute for Food Hygiene and Safety, University of Zurich, Switzerland; the 87 
Centre for Food Safety, University College Dublin, Ireland and Oxoid Ltd., Thermo Fisher Scientific, 88 
Basingstoke, UK (Table 1). The Enterobacteriaceae strains chosen for the study included 9 strains that had 89 
been previously found to be particularly sensitive to selective agents used in microbiological growth media 90 
(Joosten et al., 2008). Non-target competitors included 11 strains of Gram-positive cocci and three Bacillus 91 
strains from the Nestlé Research Centre culture collection chosen to cover a variety of species, as well as 11 92 
primary isolates of Gram-positive rods obtained from commercially available milk powders (2.2 ; Table 1).   93 
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 94 
2.2. Isolation and identification of Gram-positive background flora from powdered milk products. 95 
 96 
To provide representative background competitors, 25 g each of 15 different brands of infant 97 
formula and 1 skimmed milk powder were pre-enriched over night at 37°C in 225ml BPW (Oxoid, UK).  98 
After pre-enrichment, samples were streaked (10µl) onto tryptone soya agar (TSA) and incubated over 99 
night at 37°C.  Recovered Gram-positive strains were further characterised using API® 50 CHB test 100 
galleries (bioMérieux, France) and by 16S rRNA gene sequencing (Fasteris SA, Switzerland).   101 
 102 
2.3. Inhibitory interactions between Gram-positive strains and Enterobacteriaceae. 103 
 104 
Inhibitory interactions between the isolated Gram-positive strains and Enterobacteriaceae strains 105 
were investigated using deferred-direct cross-streaking assays on TSA and infant formula milk agar (IFMA, 106 
comprising 200 ml infant formula, 0.4 g ammonium sulphate, 3 g agar and 40 ml distilled water). Gram-107 
positive strains were streaked as single lines across agar plates using a swab and incubated overnight at 108 
30°C. The visible growth was removed using a sterile spatula or swab and, to suppress remaining viability 109 
of the Gram-positive organisms, the plates were treated with exposure to UV (60 minutes at 8mW cm-2, i.e. 110 
2880 J m-2) and/or chloroform applied directly the agar surface (5 ml per plate) for 10 min before 111 
evaporation in a fume hood.  The Enterobacteriaceae strains were then streaked as single lines at 90° to the 112 
previous Gram-positive growth, the plates were incubated overnight and the growth of the 113 
Enterobacteriaceae observed. Growth inhibition around the junctions of the bacterial streaks indicated the 114 
possible presence of inhibitory compounds produced by prior growth of Gram-positive organisms. Growth 115 
of Enterobacteriaceae  on the area of TSA and IFMA that had no previous growth of Gram-positive strains 116 
acted as an internal control for each plate indicating that any observed inhibition was not due to residual 117 
chloroform. Additionally, cell-free supernatants  from strains BcHP, Bc14, ATCC 29544T and E632 (Table 118 
1) grown overnight in brain heart infusion (BHI, Oxoid, UK) were two-fold serially diluted and the ability 119 
to suppress growth of competing strains assessed by measuring the time to detection (TTD) in a Bioscreen 120 
C (Thermofisher, UK).  121 
 122 
2.4. Comparing growth rate in skimmed milk and infant formula. 123 
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 124 
The growth rate in UHT skimmed milk (Migros) and UHT infant formula (HiPP) of two 125 
Cronobacter sakazakii strains (ATCC 29544T and E632) were determined in both pure culture and in the 126 
presence of Gram-positive competitors.  For each media sterile ready-to-use brands were used of which 250 127 
ml was inoculated with 0.1 ml of approximately 1 x 105 CFU ml-1 of the test strain(s) grown overnight in 128 
BHI and diluted in 0.9% saline. The inoculated samples were incubated at 37°C and 100 µl aliquots 129 
removed every hour over a period of 24 h.  At each time point the sample was decimally diluted in 0.9% 130 
saline to 10-8 and plate counts performed using the Miles and Misra method (Miles et al, 1938). Plate count 131 
agar (PCA, Oxoid, UK) was used to count the Gram-positive species, which were morphologically 132 
distinguishable from the Enterobacteriaceae, and TSA containing 10 mg L-1 vancomycin hydrochloride 133 
(TSA-V) to inhibit growth of Gram-positive strains was used to count the Enterobacteriaceae.   134 
 135 
2.5. Heat stability of vancomycin hydrochloride. 136 
 137 
The effect of heat on the activity of vancomycin hydrochloride was investigated using two-fold 138 
serial dilutions in BPW.  Initially separate preparations of BPW containing 0.04 g L-1 vancomycin were: i) 139 
autoclaved at 121°C for 15 min, ii) autoclaved at 115°C for 15 min and iii) heated at 100°C for 30 min. 140 
Additionally, filter sterilised vancomycin (final concentration of 0.04 g L-1) was added to BPW which had 141 
been previously autoclaved at 121°C for 15 min. The BPW-vancomycin preparations were serially diluted 142 
in 96-well microtitre plates (100 µl per well) and 100 µl of approximately 1 x 105 CFU ml-1 of the test 143 
strains (Table 1), which had been grown overnight in BHI and decimally diluted in BPW, were added. The 144 
final concentrations of vancomycin ranged from 0.02 g L-1 to 0.0003 g L-1.  The optical density (OD600 nm) 145 
of the wells was read at 0 h and after incubation for 24 h at 37°C using a Sunrise™ microplate reader 146 
(Tecan Group Ltd., Switzerland). The percentage change in OD600 nm was plotted against vancomycin 147 
concentration and the relative activity of the BPW-vancomycin preparations compared.  148 
 149 
2.6. Optimization of pre-enrichment medium: inhibition of Gram-positive organisms.  150 
 151 
Alternative antimicrobial agents were assessed in comparison to vancomycin. BPW supplemented 152 
with sodium deoxycholate was prepared by adding 1.0 g L-1 sodium deoxycholate (Sigma) to BPW prior to 153 
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autoclaving at 121°C for 15 min.  The BPW-sodium deoxycholate was then diluted to give final 154 
concentrations of 0.05, 0.1, 0.2, 0.25, 0.3, 0.4and 0.5g L-1 sodium deoxycholate after 100 µl of 2x dilution 155 
was dispensed into the wells of one row in the 96-well plate and inoculated with 100 µl of culture as above.  156 
BPW supplemented with 8-hydroxyquinoline was prepared by adding 100 mM 8-157 
hydroxyquinoline (Sigma) to BPW prior to autoclaving at 121°C for 15 min. The BPW-8-hydroxyquinoline 158 
was then diluted and inoculated as above to give final concentrations of 10, 20, 30, 40, 50, 60, 70, 80, 90, 159 
100 and 200 µM 8-hydroxyquinoline in the wells.  160 
The OD600 nm  of the plates were read at 0 h and 24 h as above. Inhibition of strains was compared 161 
by determining the concentrations that resulted in a reduction of greater than 50% of the final OD600 nm. 162 
 163 
2.7. Optimization of pre-enrichment medium: addition of ammonium iron(III) citrate and pyruvate 164 
 165 
Aliquots of UHT skimmed milk (10 ml) were either supplemented with ammonium iron(III) citrate 166 
(0.5g L-1) or sodium pyruvate (0.1g L-1). The preparations were then inoculated with Cronobacter sakazakii 167 
strain ATCC 29544T or E632 with and without Bc14 and BcHP. The samples were incubated at 37°C for 24 168 
h and 100 µl aliquots removed at 0 and 24 h.  At each time point the samples were decimally diluted in 169 
0.9% saline to 10-8 and plate counts performed. The Gram-positive species were counted on TSA and the 170 
Enterobacteriaceae were counted on TSA-V.   171 
 172 
2.8. Optimization of pre-enrichment medium: efficacy of 8-hydroxyquinoline in milk with and without 173 
ammonium iron(III) citrate. 174 
 175 
Aliquots (10 ml) of UHT skimmed milk and infant formula were supplemented with 8-176 
hydroxyquinoline to final concentrations of 0, 40, 60 and 100 µM both with and without ammonium 177 
iron(III) citrate (0.5g L-1). The preparations were then inoculated with either Cronobacter sakazakii strains 178 
ATCC 29544T, E632, or E539, or with Bacillus strain Bc14. The samples were incubated at 37°C for 24 h 179 
and 100 µl aliquots removed at 0 and 24 h.  At each time point the samples were decimally diluted in 0.9% 180 
saline to 10-8 and plate counts performed. The Bc14 strain was counted on TSA and the Cronobacter were 181 
counted on TSA-V.   182 
 183 
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2.9. Optimization of pre-enrichment medium: recovery of desiccated cells. 184 
 185 
Ten Gram-positive isolates (Bc1, Bc12a, Bc13, Bc14, BcHP, STA209, STA241, STA247, STR45 186 
and STR70) and six Enterobacteriaceae strains (E539, ATCC 29544T, E604, E617, E632 and E827) were 187 
grown overnight in BPW at 37°C.  For each strain aliquots of 10 µl (approximately 107 CFU) were placed 188 
into wells of Bioscreen C plates (n=5 for each rehydration broth).  The plates were dried for 4 hours in a 189 
sterile cabinet and then stored for one week in the dark in a sealed box containing Drierite® (Sigma) to 190 
standardize the relative humidity.  The dried cells were rehydrated with 400 µl per well of the following 191 
media: 1) BPW; 2) BPW plus 40 µM 8-hydroxyquinoline; 3) BPW plus 0.1 g L-1 sodium deoxycholate; 4) 192 
BPW plus 10 mg L-1vancomycin ; 5) BPW plus 40 µM 8-hydroxyquinoline plus 0.5g L-1 ammonium 193 
iron(III) citrate; 6) BPW plus 40 µM 8-hydroxyquinoline plus 0.1 g L-1 sodium deoxycholate; 7) BPW plus 194 
40 µM 8-hydroxyquinoline plus 0.5g L-1 ammonium iron(III) citrate plus 0.1 g L-1 sodium deoxycholate;  8) 195 
BPW plus 40 µM 8-hydroxyquinoline plus 0.5g L-1 ammonium iron(III) citrate plus 0.1 g L-1 sodium 196 
deoxycholate plus 0.1g L-1 sodium pyruvate;  9) BPW plus 0.5g L-1ammonium iron(III) citrate; 10) BPW 197 
plus 0.1g L-1sodium pyruvate. Immediately after rehydration the OD600 nm of the wells was read every 15 198 
minutes over 24 h using the Bioscreen C. The overall change in OD was calculated as the maximum OD600 199 
nm reading minus the initial background OD600 nm reading. The time-to-detection (TTD) was calculated as 200 
the time taken for the OD600 nm to increase to a value greater than twice that of the initial background OD600 201 
nm reading. The relative performance of the rehydration broths were calculated as ΔOD600 nm /TTD.  202 
Additionally, the relative recovery of strains desiccated in milk using different pre-enrichment 203 
broths was compared. Gram-positive strains and Enterobacteriaceae strains (Table 1) were grown 204 
overnight in BHI, 10 ml of the cultures were centrifuged at 10 000g for 10 min and the supernatant 205 
discarded. The cell pellet was resuspended in 1 ml of sterile UHT infant formula and the cell suspension 206 
diluted in infant formula to give concentrations of approximately 1 x 1010 to 1 x 100 CFU ml-1.  A 10 µl 207 
aliquot of each dilution was dispensed into the 8 wells of individual columns in a 96-well microtitre plate. 208 
The plates were dried for 4 h in a sterile cabinet then stored for 2 months in the dark in a sealed box 209 
containing Drierite® (Sigma). The dried cells were rehydrated with 200 µl per well of media as described 210 
above in preparations 1) to 8). The plates were incubated overnight at 37°C and, using a 96-pin replicator, 211 
approximately 1-3 µl was transferred to a 96-well plate containing 200 µl indicator medium (comprising 212 
TSA with 0.04g L-1 bromocresol purple and 10g L-1 glucose). The indicator plates were incubated at 37°C 213 
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overnight and the number of wells in each column positive for growth and glucose fermentation was 214 
recorded. Adjusting appropriately for the dilution factors, the MPN was calculated using the Bacteriological 215 
Analytical Manual Online MPN tables (available at http://www.cfsan.fda.gov/~ebam/bam-a2.html; 216 
accessed 19-10-2008). 217 
 218 
2.10. Comparison of methods for recovery of Enterobacteriaceae from artificially inoculated samples. 219 
 220 
The optimum modified BPW supplemented with 40 µM 8-hydroxyquinoline, 0.5g L-1 ammonium 221 
iron(III) citrate, 0.1 g L-1 sodium deoxycholate and 0.1g L-1 sodium pyruvate (BPW-S) was chosen based on 222 
the rehydration experiments above. This was then compared to ISO 21528-1:2004 with and without EE 223 
broth as well as to rehydration with BPW containing 10 mg L-1 vancomycin (BPW-V).  224 
To prepare the artificial inoculum, skimmed milk from a local commercial retailer was 225 
concentrated to 29% solids using a climbing film evaporator drawing a -0.95 bar vacuum. Microbial 226 
cultures of the following Enterobacteriaceae strains (LMG 23827T, LMG 23823T, ATCC 29544T, ATCC 227 
12868, ATCC 51329T, E604, E632, NCTC 9529, LMG 23826T, E934, OCC118 and OCC2758) were 228 
grown overnight at 37°C in Nutrient broth No. 2 (Thermo Fisher Scientific, UK). The microbial cultures 229 
were inoculated into separate 400 ml aliquots of the evaporated milk at a ratio of 1:100, to give a final 230 
concentration of approximately 1 x 103 CFU/ml. The solutions were then spray dried using a Lab-Plant SD-231 
04 (Lab-Plant Ltd., UK.) with the outlet temperature set at 150°C.  The spray-drier was decontaminated 232 
between each organism using a 1% sodium hydroxide solution and the cleaning was validated by swabbing 233 
the equipment and observing for growth on TSA and DFI agar plates after overnight incubation. The 234 
concentration of Enterobacteriaceae in the spray-dried powders was determined using an MPN method 235 
which involved the rehydration of triplicate 10 g, 1 g and 0.1 g aliquots in BPW and incubation overnight at 236 
37°C. The BPW was sampled with a 10 µl loop and streaked on to DFI agar. The inoculation powders were 237 
diluted by mixing with commercial powdered milk to give approximately 1 CFU/g of spray-dried 238 
Enterobacteriaceae.   239 
Test samples were prepared using 5-10 g aliquots of the inoculation powder samples made up to 240 
25 g using skimmed milk powder. Triplicate 25 g aliquots were subsequently rehydrated using 225 ml of 241 
BPW, BPW-V, and BPW-S. All the rehydrated samples were incubated at 37°C for 18 ± 2 h after which 242 
plate counts were performed on VRBGA and TSA-V.  Also, 1 ml of the BPW rehydrated samples was 243 
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transferred to 10 ml EE broth and incubated at 37°C for 24 ± 2 h before plate counts on VRBGA and TSA-244 
V.  The plate count media was incubated at 37°C for 24 ± 2 h and the colonies identified as 245 
Enterobacteriaceae based on the oxidase test and fermentation of glucose. 246 
 247 
2.11. Comparison of methods for recovery of Enterobacteriaceae from naturally contaminated samples. 248 
 249 
Ninety-seven different food and environmental matrices were obtained from three different 250 
companies. These comprised 29 infant formula products; 5 infant foods; 3 confectionary products; 13 251 
flour/starch/semolina/grain samples; 4 milk proteins; 9 sugar/syrup samples; 4 cocoa powders; 5 malt 252 
drinks; 4 vegetable powders; 2 fruit powders; 1 roasted nut sample; 1 vanilla flavouring sample; 2 253 
vitamin/mineral mixes; and 15 environmental samples from production facilities. The samples were divided 254 
into 6 x 25 g aliquots; three aliquots were diluted 1:10 in BPW and three were diluted 1:10 in BPW-S. The 255 
rehydrated samples were incubated at 37°C for 18 ± 2 h and plate counts performed on PCA and VRBGA 256 
to detect Gram-positive background flora and Enterobacteriaceae respectively. Also, 1 ml of the BPW 257 
rehydrated samples was transferred to 10 ml EE broth, incubated at 37°C for 24 ± 2 h and plate counts 258 
performed. In all cases, the plate count media was incubated at 37°C for 24 ± 2 h and the colonies identified 259 
as Enterobacteriaceae based on the oxidase test and fermentation of glucose. Each sample was tested in 260 
triplicate using all three methods. 261 
 262 
 263 
3. Results 264 
 265 
3.1. The influence of Gram-positive background flora on the growth of Enterobacteriaceae 266 
 267 
A total of 11 Bacillus strains were isolated from the milk powder and infant formula samples (2.2). 268 
The identification results are given in Table 1. The cross-streaking assays on TSA and IFMA indicated that 269 
prior growth of strain Bc14 was inhibitory to the growth of some Enterobacteriaceae, particularly E632, 270 
whereas the prior growth  of BcHP was not. In the Bioscreen C assays using cell-free supernatants the TTD 271 
for E632 was 7.25 h in BPW with and without the presence of BcHP filtrate, however the TTD increased to 272 
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10.5 h in the presence of Bc14 filtrate. The TTD for ATCC 29544T was 5 h in all experiments (data not 273 
shown).  274 
The growth rate of Cronobacter sakazakii strain ATCC 29544T was the same in skimmed milk and 275 
in infant formula and was not affected by the presence of BcHP. The growth rate of strain E632 was slower 276 
than that of ATCC 29544T in infant formula, and in skimmed milk growth of E632 was not detected 277 
without the presence of BcHP. In both growth media, E632 only reached a comparable final concentration 278 
to ATCC 29544T when BcHP was present. Additionally, in the presence of ATCC 29544T, strain Bc14 was 279 
not recovered whereas the growth of strain BcHP was not affected (data not shown). 280 
 281 
3.2. Optimization of pre-enrichment medium: inhibition of Gram-positive organisms  282 
 283 
The addition of sterile solutions of vancomycin did not inhibit the growth of the 284 
Enterobacteriaceae at 40 mg L-1. Autoclaving vancomycin solutions at 115 °C or 121 °C for 15 minutes 285 
reduced their activity against Gram-positive organisms. All BPW-vancomycin preparations with a final 286 
concentration equivalent to 10 mg L-1 were able to inhibit the growth of Gram-positive organisms. No 287 
reduction in activity was seen for vancomycin solutions boiled for 30 minutes when compared to a filter-288 
sterilised solution (data not shown). 289 
An increase in OD600 nm was not detected for any of the Gram-positive strains in the presence of a 290 
8-hydroxyquinoline concentration of 10 µM or above. The effect of 8-hydroxyquinoline on 291 
Enterobacteriaceae strains was variable with most strains uninhibited below 100µM. Strains E540, E604, 292 
E617 and E827 were inhibited between 60-80 µM and one strain, E539, showed growth inhibition at 30 µM 293 
(data not shown).  294 
The growth of the majority of the Staphylococcus and Bacillus strains was reduced by sodium 295 
deoxycholate at 0.1 g L-1 with no growth detected at concentrations > 0.3 g L-1. The growth of strains 296 
STA241 and STA209 was reduced at 0.3 g L-1 and no growth was detected at concentrations of 0.4 and 0.5 297 
g L-1 respectively.  The Enterococcus strains appeared to be unaffected by the sodium deoxycholate at the 298 
concentrations used. Growth occurred for all of the Enterobacteriaceae at all concentrations of sodium 299 
deoxycholate,  however, at concentrations ≥ 0.2 g L-1 strains E540, E632, E770 and E827 displayed reduced 300 
growth with the increase in OD600 nm only reaching 20-40 % of the values obtained in BPW alone (data not 301 
shown).  302 
12 
 
 303 
3.3. Optimization of pre-enrichment medium: addition of ammonium iron(III) citrate 304 
 305 
When grown in infant formula and skimmed milk with and without the additions of 8-306 
hydroxyquinoline and ammonium iron(III) citrate the final CFU ml-1 obtained for strain ATCC 29544T was 307 
comparable across all experimental conditions. Strain E632 could not be recovered from skimmed milk 308 
without the addition of ammonium iron(III) citrate. Also, strain E539 grew poorly in skimmed milk 309 
supplemented with 8-hydroxyquinoline alone, reaching only approximately 102 CFU ml-1. When 310 
ammonium iron(III) citrate was added to skimmed milk along with 8-hydroxyquinoline the recovery of 311 
E632 and E539 improved to final CFU ml-1 concentrations comparable to that obtained when these strains 312 
were grown in infant formula.   Strain Bc14 grew better in infant formula than in skimmed milk reaching 313 
concentrations of approximately 108 and 104 CFU ml-1 respectively in these media. In infant formula no 314 
growth was detected for Bc14 in the presence of 8-hydroxyquinoline. In skimmed milk no growth was 315 
detected in the presence of 8-hydroxyquinoline when ammonium iron(III) citrate was also present. When 316 
supplemented with 8-hydroxyquinoline alone growth was detected in the presence of 40 and 60 µM but not 317 
100 µM of this compound. The additional of ammonium iron(III) citrate to infant formula did not appear to 318 
affect the recovery of Enterobacteriaceae strains or to improve their growth (Figure 1).  319 
 320 
3.4. Optimization of pre-enrichment medium: recovery of desiccated cells 321 
 322 
When desiccated cells were rehydrated using BPW supplemented with 8-hydroxyquinoline and 323 
sodium deoxycholate either alone or in combination no Gram-positive strains were recovered. However 324 
these media also failed to recover all of the Enterobacteriaceae strains. Addition of ammonium iron(III) 325 
citrate and/or sodium pyruvate improved recovery of strains. Rehydration of desiccated cells using BPW-S 326 
(BPW supplemented with 40 µM 8-hydroxyquinoline, 0.5g L-1 ammonium iron(III) citrate, 0.1 g L-1 sodium 327 
deoxycholate and 0.1g L-1 sodium pyruvate) was determined to give the best recovery of 328 
Enterobacteriaceae while inhibiting the growth of Gram-positive organisms. All Enterobacteriaceae 329 
desiccated in milk were recovered at ≥ 105 MPN ml-1 using this medium with the majority of strains 330 
recovered at ≥ 108 MPN ml-1.  Recovery of Gram-positive strains ranged from 103 to 1010 MPN ml-1 in 331 
BPW alone, however, using BPW-S no Gram positives were recovered at ≥ 103 MPN ml-1 (data not shown).    332 
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 333 
3.5. Comparison of methods for recovery of Enterobacteriaceae from artificially inoculated and naturally 334 
contaminated  samples 335 
 336 
When powdered milk samples were artificially inoculated with lyophilised strains and recovered 337 
using the different methods, the BPW-S enrichment method resulted in consistently higher CFU ml-1 for the 338 
Enterobacteriaceae strains than the ISO 21528 and shortened methods. The final concentration of target 339 
cells was > 105 CFU ml-1 for all of the Enterobacteriaceae strains using BPW-S with a mean log10 CFU ml-340 
1 of 7.5 compared to 6.3, 5.0 and 6.9 mean log10 CFU ml-1 for the other methods (Table 2). Using a two-341 
sample student t-test assuming unequal variances there was a significant difference (P=0.045) between the 342 
ISO 21528 and the BPW-S methods; no significant differences were found between ISO 21528 and the 343 
other two methods for this data set of artificially contaminated samples. 344 
A total of 291 samples were tested from the 97 food and environmental matrices with the three methods 345 
(Table 3). Enterobacteriaceae were recovered from 106 samples after enrichment in BPW-S compared to 346 
91 and 87 positive samples found using ISO 21528 and the shortened procedure respectively, however, 347 
using a two-sample student t-test assuming unequal variances, the differences between ISO 21528 and the 348 
other methods was not significant for this data set of naturally contaminated matrices. 349 
 350 
4. Discussion 351 
The family Enterobacteriaceae are useful indicators for verification of hygiene processes in food 352 
production facilities (Anonymous, 2005). A revision to the ISO standard method (21528-1:2004) has been 353 
proposed in which the selective enrichment in EE broth is omitted and samples pre-enriched in BPW are directly 354 
plated on VRBG agar (Joosten et al., 2008). Non-target organisms present in the sample may compete with the 355 
Enterobacteriaceae during pre-enrichment. This is of particular concern for milk powders which often contain 356 
thermoduric spores in excess of the levels of Enterobacteriaceae (Murphy et al., 1999).  This study investigates 357 
novel cost effective modifications, designed to improve ISO 21528-1:2004 for the detection of 358 
Enterobacteriaceae.  359 
The Gram-positive rods chosen for this study were isolated from milk products to ensure representative 360 
background organisms were used as competitive flora during development and assessment of the method. To 361 
provide a worst case scenario, the choice of target strains was directed to isolates previously shown to be 362 
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sensitive to selective agents included in media commonly used for recovery of Enterobacteriaceae. Cronobacter 363 
spp. (Enterobacter sakazakii) have been shown to be more sensitive to antibiotics than related 364 
Enterobacteriaceae (Stock and Wiedemann, 2002) and sensitivity of several isolates  to dyes and/or bile salts 365 
has been reported (Joosten et al., 2008). The interaction between the Gram-positive strains and the target 366 
Enterobacteriaceae appeared complex with certain Bacillus strains, such as BcHP, increasing the growth of 367 
target strains such as E632 in milk powder. This may be due to metabolism of the media by BcHP, releasing 368 
components otherwise unavailable to E632 or to degradation of inhibitory substances. Growth of all the Bacillus 369 
strains on 1% skimmed milk agar and IFMA agar produced zones of clearing (data not shown). Bacillus spp. 370 
and related genera are equipped with a wide variety of genes for metabolic and catabolic processes. They have a 371 
range of hydrolytic enzymes that allow them to use macromolecules such as proteins (Chopra and Mathur, 1984; 372 
El Mayda et al., 1986; Kalogridou-Vassiliadou, 1992), carbohydrates (Kalogridou-Vassiliadou, 1992)  and 373 
phospholipids (Drobniewski, 1993; Titball, 1993) as nutrients. Other Gram-positive strains appeared to inhibit 374 
growth of E632, either by competing for nutrients or producing inhibitory compounds. Strain Bc14 was 375 
identified as Bacillus velezensis, which species has been reported to produce a high amount of surfactant that 376 
has antimicrobial properties (Ruiz-García et al., 2005). A reduced growth rate was evident for E632 in the 377 
presence of the Bc14 filtrate but not that of BcHP.  Interestingly, it was also evident that some 378 
Enterobacteriaceae strains, such as ATCC 29544T are able to inhibit the growth of Gram-positive organisms 379 
such as Bc14 (data not shown). The exact nature of the inhibitory mechanisms was not investigated in this 380 
study, it was concluded that as the composition of background flora is unknown in food samples the appropriate 381 
strategy would be to add components to the recovery medium to inhibit the non-target Gram-positive organisms 382 
and also to promote the growth of target strains. 383 
It has been shown that addition of vancomycin hydrochloride at 10 mg L-1 during pre-enrichment may 384 
increase recovery of Enterobacteriaceae (Joosten et al., 2007).  The heat stability of vancomycin hydrochloride 385 
was investigated and although a reduction in activity was evident after autoclaving at 121°C and 115°C for 15 386 
min, the Gram-positive strains were inhibited by preparations containing 10 mg L-1. However, the cost, and 387 
concerns regarding the possible spread of vancomycin resistance genes (Willems et al., 2005), still means viable 388 
alternative additives to vancomycin are desirable.  Therefore we investigated the use of 8-hydroxyquinoline and 389 
sodium deoxycholate to inhibit Gram-positive organism during pre-enrichment of Enterobacteriaceae.  390 
Sodium deoxycholate is the selective agent in bile salts and is commonly used in culture media for 391 
selection of Gram-negative organisms. The lipophilic nature of the 8-hydroxyquinoline-iron complex allows it 392 
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to diffuse through cell membranes, however its precise mode of anti-bacterial action is as yet unproven. It has 393 
been suggested that 8-hydroxyquinoline transiently inhibits growth of E. coli by chelating metal cations that are 394 
essential for RNA polymerase to function (Collins et al., 1979). This seems unlikely in view of the fact that 8-395 
hydroxyquinoline induces expression of manganese containing superoxide dismutase (MnSOD) in E. coli (Pugh 396 
and Fridovich, 1985). It has been found that exposure to 8-hydroxyquinoline-iron complex caused extreme 397 
DNA strand breakage as well as formation of substantial lipid peroxidation products in cultured lung cells 398 
(Leanderson and Tagesson, 1996). Iron promotes lipid peroxidation by increasing the formation of oxygen 399 
radicals. Cellular levels of iron in the lung cells were three-fold higher after exposure to 8-hydroxyquinoline-400 
iron than to other iron chelates and the cellular concentration of malondialdehyde (a marker for oxidative stress) 401 
increased four-fold. The 8-hydroxyquinoline-iron complex may generate superoxide anions and possibly acts as 402 
a chemical nuclease inducing site-specific breaks by oxidatively degrading the deoxyribose moiety (Leanderson 403 
and Tagesson, 1996). In this study co-addition of ammonium iron(III) citrate appeared to be important to 404 
facilitate the antimicrobial action of 8-hydroxyquinoline in skimmed milk powder.  Supplementation with 405 
ammonium iron(III) citrate also had the dual effect of improving recovery of some Enterobacteriaceae strains.  406 
This may be due to lack of sufficient free iron in the milk powder, possibly due to sequestration by lactoferrin. 407 
Addition of iron(III) ions may saturate iron binding proteins in the milk and provide available free iron for 408 
microbial growth. Infant formula powders are routinely supplemented with iron, usually at a concentration of 409 
4.0–12 mg L-1 as is recommended to reduce the prevalence of iron-deficiency anaemia (American Academy of 410 
Pediatrics, 1999). Therefore the additional of ammonium iron(III) citrate to infant formula was not essential to 411 
the antimicrobial action of 8-hydroxyquinoline and did not increase the growth of Enterobacteriaceae. 412 
However, the additional iron in BPW-S did not appear to be detrimental to growth of Enterobacteriaceae or to 413 
the inhibition of Gram-positive organisms. It can therefore be concluded that a universal supplementation of 414 
BPW with iron can be used for both low and high iron-containing samples.   415 
A combination of both sodium deoxycholate and 8-hydroxyquinoline provided the most effective 416 
inhibition of the range of Gram-positive organisms tested. However, addition of ammonium iron(III) citrate and 417 
sodium pyruvate, which protects desiccation stressed bacteria from peroxide ions (McDonald et al., 1983), was 418 
necessary to improve recovery of desiccation stressed Enterobacteriaceae. The optimal enrichment broth in this 419 
study was determined to be BPW supplemented with 40 µM 8-hydroxyquinoline, 0.5g L-1 ammonium iron(III) 420 
citrate,  0.1 g L-1 sodium deoxycholate and 0.1g L-1 sodium pyruvate (BPW-S). This medium gave consistently 421 
greater final concentrations of target cells when skimmed milk powder was artificially contaminated with low 422 
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levels of lyophilised Enterobacteriaceae cells. The composition of pre-enrichment broth is modified by addition 423 
of the sample at a 1:10 ratio and matrix components may change the inhibitory (and growth promoting) 424 
properties of the homogenate. However, the results in table 3 show that BPW-S seems to be suitable for a 425 
variety of matrices as this method also detected endogenous Enterobacteriaceae in significantly more of the 426 
naturally contaminated food and environmental matrixes tested than did the ISO 21528-1:2004 or the shortened 427 
method. 428 
Improvements to the composition of BPW with a view to inhibition of competing Gram-positive 429 
background flora may potentially improve recovery of Gram-negative organisms from samples. This method 430 
may have useful application as a pre-enrichment step in other microbiological culture methods for recovery of 431 
Gram-negative pathogens, such as Salmonella and Cronobacter, as well as indicator organisms. 432 
 433 
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